Loading...
Chronic myeloid leukemia: mechanisms of blastic transformation
The BCR-ABL1 oncoprotein transforms pluripotent HSCs and initiates chronic myeloid leukemia (CML). Patients with early phase (also known as chronic phase [CP]) disease usually respond to treatment with ABL tyrosine kinase inhibitors (TKIs), although some patients who respond initially later become r...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2898591/ https://ncbi.nlm.nih.gov/pubmed/20592475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI41246 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|